A 8weeks, Double blind, Randomized Comparative Clinical Trial Comparing The Efficacy and Safety between UDB and DDB for Chonic Hepatitis: Phase III Study

Dong Kyun Son; Jae Kwang Kim; Dae Young Cheung; U Im Chang; Soo-Heon Park; Jin Mo Yang; Joon-Yeol Han; Kyu Won Chung; Hee Sik Sun

doi:10.12793/jkscpt.2004.12.1.57

A 8weeks, Double blind, Randomized Comparative Clinical Trial Comparing The Efficacy and Safety between UDB and DDB for Chonic Hepatitis: Phase III Study

Journal of Korean Society for Clinical Pharmacology and Therapeutics ◽

10.12793/jkscpt.2004.12.1.57 ◽

2004 ◽

Vol 12 (1) ◽

pp. 57

Author(s):

Dong Kyun Son ◽

Jae Kwang Kim ◽

Dae Young Cheung ◽

U Im Chang ◽

Soo-Heon Park ◽

...

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Comparative Clinical Trial ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study

Journal of Korean Society of Spine Surgery ◽

10.4184/jkss.2016.23.2.92 ◽

2016 ◽

Vol 23 (2) ◽

pp. 84

Author(s):

Ki Taek Kim ◽

Tae Kyun Kim ◽

Ji Woong Choi ◽

Jae Sung Ahn ◽

Young Do Koh ◽

...

Keyword(s):

Back Pain ◽

Sustained Release ◽

Chronic Back Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study

Download Full-text

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis

Arthritis Research & Therapy ◽

10.1186/s13075-017-1371-4 ◽

2017 ◽

Vol 19 (1) ◽

Cited By ~ 10

Author(s):

Ahmadreza Jamshidi ◽

Farhad Gharibdoost ◽

Mahdi Vojdanian ◽

Soosan G. Soroosh ◽

Mohsen Soroush ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Active Rheumatoid Arthritis ◽

Reference Product ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Cited By ~ 49

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase

Download Full-text

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Advances in Therapy ◽

10.1007/s12325-021-01899-0 ◽

2021 ◽

Author(s):

Lin Cai ◽

Linfeng Li ◽

Hao Cheng ◽

Yangfeng Ding ◽

Zhenshu Biao ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Phase Iii Study

Download Full-text

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-1098 ◽

2019 ◽

Vol 25 (10) ◽

pp. 3193-3193

Author(s):

Nicholas Thatcher ◽

Jerome H. Goldschmidt ◽

Michael Thomas ◽

Michael Schenker ◽

Zhiying Pan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Study

Download Full-text